T. Rowe Price Health Sciences Fund, Inc. · net assets $11.9B · 279 holdings as of June 30, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 96.3% · EP: 2.9% · STIV: 0.6% · DBT: 0.1%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $552M | $42.3M | $64.8M |
| Reinvestment | $0 | $0 | $0 |
| Redemptions | $699M | $206M | $218M |
| Net realized gain (non-derivative) | $879M | $341M | $323M |
| Net unrealized appreciation (non-derivative) | $-704M | $38.2M | $634M |
The three months of the reporting period, as filed; month 3 ends June 30, 2026.
| Tenor | Investment grade | Non-investment grade |
|---|---|---|
| 3 months | $0 | $0 |
| 1 year | $0 | $0 |
| 5 years | $0 | $0 |
| 10 years | $0 | $0 |
| 30 years | $0 | $0 |
| Holding | Value | % of net assets |
|---|---|---|
| Eli Lilly & Co EC | $1.71B | 14.28% |
| Johnson & Johnson EC | $792M | 6.63% |
| Unitedhealth Group Inc EC | $716M | 5.99% |
| Abbvie Inc EC | $609M | 5.10% |
| Merck & Co. Inc. EC | $479M | 4.01% |
| Gilead Sciences Inc EC | $337M | 2.82% |
| Thermo Fisher Scientific Inc EC | $301M | 2.52% |
| Vertex Pharmaceuticals Inc EC | $272M | 2.28% |
| Bristol-myers Squibb Co EC | $252M | 2.11% |
| Abbott Laboratories EC | $225M | 1.89% |
| Intuitive Surgical Inc EC | $224M | 1.87% |
| Amgen Inc EC | $217M | 1.82% |
| Stryker Corp EC | $213M | 1.78% |
| Elevance Health Inc EC | $183M | 1.53% |
| Natera Inc EC | $172M | 1.44% |
| Danaher Corp EC | $170M | 1.43% |
| Guardant Health Inc EC | $146M | 1.23% |
| Cardinal Health Inc EC | $123M | 1.03% |
| Royalty Pharma Plc- Cl A EC | $116M | 0.97% |
| Cvs Health Corp EC | $112M | 0.94% |
| Tenet Healthcare Corp EC | $112M | 0.94% |
| Kymera Therapeutics Inc EC | $106M | 0.89% |
| Protagonist Therapeutics Inc EC | $102M | 0.85% |
| Moderna Therapeutics Inc EC | $98.9M | 0.83% |
| Brightspring Health Services EC | $98.3M | 0.82% |
| Revolution Medicines Inc EC | $92.8M | 0.78% |
| Roivant Sciences Ltd EC | $84M | 0.70% |
| Alnylam Pharmaceuticals Inc EC | $80.2M | 0.67% |
| Viatris Inc EC | $78.6M | 0.66% |
| Charles River Laboratories EC | $74M | 0.62% |
| Argenx Se - ADR EC | $71.1M | 0.60% |
| Edwards Lifesciences Corp EC | $70.6M | 0.59% |
| Centene Corp EC | $67.9M | 0.57% |
| Spyre Therapeutics Inc EC | $63.2M | 0.53% |
| Definium Therapeutics Inc EC | $60.6M | 0.51% |
| T. Rowe Price Government Reserve Fund STIV | $60.1M | 0.50% |
| Insmed Inc EC | $58.5M | 0.49% |
| Twist Bioscience Corp EC | $57.1M | 0.48% |
| Parabilis Medicines, Inc. Lockup Shares Pp EC | $56M | 0.47% |
| Chugai Pharmaceutical Co Ltd EC | $54.1M | 0.45% |
| Astrazeneca PLC EC | $52.9M | 0.44% |
| United Therapeutics Corp EC | $52.4M | 0.44% |
| Krystal Biotech Inc EC | $51.6M | 0.43% |
| Boston Scientific Corp EC | $51.1M | 0.43% |
| Medtronic PLC EC | $49.3M | 0.41% |
| Erasca Inc EC | $47.3M | 0.40% |
| Billiontoone Inc Cl A EC | $45.3M | 0.38% |
| Praxis Precision Medicines I EC | $44.6M | 0.37% |
| Medpace Holdings Inc EC | $44.6M | 0.37% |
| Monte Rosa Therapeutics Inc EC | $44.1M | 0.37% |
| Tango Therapeutics Inc EC | $43.8M | 0.37% |
| Oruka Therapeutics Inc EC | $42.9M | 0.36% |
| Ascendis Pharma A/s EC | $42.6M | 0.36% |
| Beone Medicines Ltd EC | $42.3M | 0.35% |
| Humana Inc EC | $42.2M | 0.35% |
| Dianthus Therapeutics Inc EC | $41.8M | 0.35% |
| Scholar Rock Holding Corp EC | $40.6M | 0.34% |
| Kodiak Sciences Inc EC | $39.5M | 0.33% |
| Axsome Therapeutics Inc EC | $37M | 0.31% |
| Summit Therapeutics Inc EC | $36.9M | 0.31% |
Showing top 60 of 279 holdings.
Loading...
